In the realm of small-cap medical companies, Ontrak and NewGenIvf Group stand out. Both businesses operate in the healthcare sector, but which one is the better investment opportunity? Let’s compare the two companies based on various factors such as risk, valuation, dividends, institutional ownership, analyst recommendations, earnings, and profitability.
Earnings & Valuation:
When it comes to gross revenue and earnings per share, NewGenIvf Group outperforms Ontrak. Although NewGenIvf Group has lower revenue, its earnings are higher than that of Ontrak.
Analyst Recommendations:
According to research analysts, Ontrak has a consensus target price of $3.00, suggesting a potential upside of 1,335.41%. This indicates that analysts believe Ontrak is more favorable compared to NewGenIvf Group, which has a lower probable upside.
Profitability:
In terms of net margins, return on equity, and return on assets, NewGenIvf Group surpasses Ontrak.
Institutional & Insider Ownership:
Institutional investors hold 66.2% of NewGenIvf Group shares, while only 12.9% of Ontrak shares are held by institutional investors. Additionally, 31.8% of NewGenIvf Group shares are held by company insiders, whereas only 1.6% of Ontrak shares are held by insiders. These figures indicate that NewGenIvf Group enjoys stronger institutional ownership and insider confidence.
Risk & Volatility:
Ontrak has a beta of 2.58, making its stock price 158% more volatile than the S&P 500. On the other hand, NewGenIvf Group has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500.
In summary, NewGenIvf Group outperforms Ontrak in six out of the eleven factors compared between the two stocks. While Ontrak shows potential with a higher target price, NewGenIvf Group exhibits stronger profitability, institutional ownership, and lower volatility.
Ontrak, Inc., headquartered in Miami, Florida, operates as an artificial intelligence-powered, telehealth-enabled, and virtualized healthcare company. It provides in-person services to third-party payors in the United States. Ontrak’s technology-enabled platform predicts individuals whose chronic diseases can improve with behavior change, recommends effective care pathways, and guides them through the necessary care. The company’s OnTrak program integrates evidence-based psychosocial and medical interventions, delivered in-person or via telehealth, to address behavioral conditions that cause or exacerbate chronic medical conditions.
NewGenIvf Group, based in Singapore, is a blank check company known as A SPAC I Acquisition Corp. It aims to merge, acquire assets, or engage in related business combinations with one or more businesses.